A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease

NCT05238597 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: A197 Ophthalmic Solution
DRUG: A197 Vehicle Control
DRUG: Active Comparator

Sponsor

Aramis Biosciences, Inc.